Trustees are elected by the ASO Membership and serve a three year term. Vacancies are advertised to the Membership when they become available and an on line ballot run if nominations exceed the number of vacancies.
If you wish to contact a Trustee, please email the ASO office at email@example.com
Chair: Professor Jason Halford
Professor Jason Halford is Head of the Department of Experimental Psychology at the University of Liverpool and Chair of the UK Association for the Study of Obesity.
He performed his undergraduate and postgraduate in the late 1980′s and early 1990′s focusing on satiety and the development of anti-obesity drugs. Some of this included early work on sibutramine. He has been involved in the behavioural assessment of potential anti-obesity drugs in pre-clinical models and humans ever since, including recent work on Rimonabant.
Over the past 10 years Jason’s research has focused on drug induced weight gain, the effects of nutrients and fibre on appetite and hormone release, the effects of stress on eating behaviour, and on lean obese differences in the expression of appetite. More recently, he has focused on the effects of branding and food promotion on children’s food preferences and diet. Jason is Professor at the University of Liverpool and Director of the Human Ingestive Behaviour Laboratory and the Liverpool Obesity Research Network.
Deputy Chair: Professor Pinki Sahota
Pinki Sahota is Professor of Nutrition and Childhood Obesity in the School of Health and Wellbeing, Leeds Metropolitan University.
Pinki has extensive experience as a community dietitian. Her areas of interest are in the area of childhood nutrition and its impact in the development of obesity. She has been involved in developing, implementing and evaluating multi-component interventions for the prevention and treatment of childhood obesity within community settings. Pinki’s specific expertise is in the area of dietary behaviour change, dietary assessment and evaluation of complex interventions. She is currently developing interventions targeting early obesity prevention as part of a study in collaboration with RCPCH and also locally with Children Centres in Leeds.
Treasurer: Dr Dilys Freeman
Dr Dilys Freeman is Senior Lecturer at the Institute of Cardiovascular and Medical Sciences, University of Glasgow.
After studying Biochemistry at the University of Edinburgh, Dilys undertook her PhD in industry at Glaxo Group Research in Middlesex. Postdoctoral positions in Glasgow and the University of Texas Southwestern Medical Center at Dallas were followed by her first academic appointment in Biological Science at the University of Durham. Dr Dilys Freeman joined the University of Glasgow in 1999. Her early research was in the field of cardiovascular disease in particular lipid and lipoprotein metabolism. She studied cholesteryl ester transfer protein and its role in high density lipoprotein metabolism as well as the genetic regulation of plasma high density lipoprotein and low density lipoprotein levels. Dilys has been involved in the analysis of the West of Scotland Coronary Prevention Study (WOSCOPS), in particular the influence of inflammation, statins and genetics on the aetiology of type 2 diabetes. Her current research is in the field of metabolism in pregnancy and its vascular complications such as preeclampsia and growth restriction. Again the focus is on lipid and carbohydrate metabolism, inflammation and the influence of genetic markers in obese pregnancy and on the development of adverse pregnancy outcome. The link between pregnancy complications and future maternal cardiovascular disease is an important part of this research. The metabolic cross-talk between mother and baby and its regulation by the placenta is also an area of interest.
Secretary: Dr Adrienne Cullum
Dr Adrienne Cullum is an Analyst at the Centre for Public Health, National Institute for Health and Care Excellence (NICE).
Adrienne has a degree in nutrition and a PHD in social medicine. Adrienne has been the technical lead for a range of NICE public health guidance on obesity. She has also worked at the Department of Health and in health promotion.
As well as being Secretary to the Board of Trustees, Adrienne’s significant contribution to the work of the ASO includes implications of research on policy and vice versa; development of ASO response to national consultations; relevance of ASO to those with public health remit in local authorities or communities; organisational best practice in relation to issues such as stakeholder engagement, declarations of interests, conflict of interests etc.
Professor Paul Aveyard
Paul Aveyard is Professor of Behavioural Medicine, University of Oxford
Paul is a GP and public health physician. He trained in public health in Birmingham and started work in the University of Birmingham in tobacco control. He then returned to clinical practice to complete training as a GP. Over the past few years Paul has started work in the field of weight control, particularly in the area of the contribution that primary care can make to weight loss. He is involved in several clinical trials, systematic reviews, and other studies in the area of weight control.
Dr Maria Bryant
Dr Maria Bryant is Senior Research Fellow and Lead for Diet and Obesity Portfolio at Leeds Institute for Clinical Trials Research, University of Leeds.
With a background in nutrition and psychology, Maria’s research focuses on aetiology and solutions to childhood obesity. Her work in this area includes clinical trials and research focused on the development and/or evaluation of appropriate outcome measures. Dr Bryant also has a unique experience in the development of home food inventory tools and intimate knowledge of the voluminous details involved in this research, including details on the methodology for training, collecting data, quality assurance and dissemination.
Dr Bryant is the Trustee leading the ASO’s work with young investigators and PPI.
Dr Catherine Hankey
Dr Catherine Hankey is Senior Lecturer in Human Nutrition, University of Glasgow.
Catherine is a nutritionist and registered dietitian, with a primary interest in dietary approaches to treat obesity. In particular, Catherine’s current research focus is to:1. Devise and evaluate specific interventions in different population groups and settings. This includes adults with intellectual disability and workplace based interventions. 2. Analyse the effect of smoking on body weight and the effectiveness of weight management alongside cessation in preventing weight gain.3. Evaluate epidemiological data to examine relationships between body weight, diet and lifestyle factors.
Catherine leads the obesity module within the University of Glasgow’s M.Sc. in Human Nutrition. She is a registered Public Health Nutritionist and member of the BDA Special Interest Group for dietitians in the UK obesity management group. She has received funding from a number of charities and funding bodies including the Food Standards Agency, and provides a nutrition consultancy to a large employer in central Scotland.
Catherine brings to the Board her expertise in obesity research and practice, drawing up conference programmes and insight into dietetics.
Professor Susan Jebb
Susan Jebb is Professor of Diet and Population Health in the Department of Primary Care Health Sciences at University of Oxford.
Susan’s research is focused on the role of diet in the prevention and treatment of obesity and related cardiovascular risk. She has a particular interest in the translation of science into policy and practice and works closely with DH, PHE and NICE. See also: http://www.phc.ox.ac.uk/team/researchers/susan-jebb .
As a long standing member of the ASO Trustees, and former Chair, Susan has organised a number of the ASO’s scientific meetings and is currently developing the plans for the new 2 day meeting to be held in 2014. Susan contributes to the ASO response to public consultations and responds to a number of media enquiries referred to ASO.
Professor John Wilding
John Wilding is Professor of Medicine and Honorary Consultant Physician at University Hospital, Aintree, Liverpool.
John Wilding is Head of the Department of Obesity and Endocrinology at the University of Liverpool, UK. He trained in medicine in Southampton and at the Hammersmith Hospital, London where he also undertook three years laboratory-based research into the neurobiology of obesity and diabetes. He has worked at University Hospital Aintree, Liverpool since 1996 and as Professor of Medicine since 2005. He has published over two hundred papers, chapters and review articles related to his clinical and laboratory research interests in type 2 diabetes and obesity. His clinical research focuses on the pathophysiology of obesity and diabetes and evaluation of new treatments. He is Chair of the UK National Clinical Research Network Metabolic and Endocrine Speciality Group. He leads specialist services for severe obesity at University Hospital Aintree – recently designated as a Centre for Obesity Management by the European Association for the Study of Obesity. A long standing member of the Board of Trustees, John was Chair of the ASO 2005-2008.